These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 17953275)
41. Goals and outcomes for non ambulant children receiving continuous infusion of intrathecal baclofen. Gray N; Morton RE; Brimlow K; Keetley R; Vloeberghs M Eur J Paediatr Neurol; 2012 Sep; 16(5):443-8. PubMed ID: 22277771 [TBL] [Abstract][Full Text] [Related]
42. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump. Krach LE; Nettleton A; Klempka B Pediatr Rehabil; 2006; 9(3):210-8. PubMed ID: 17050399 [TBL] [Abstract][Full Text] [Related]
43. Intrathecal baclofen in the management of spasticity due to cerebral palsy. Vloeberghs M; Keetley R; Morton R Pediatr Rehabil; 2005; 8(3):172-9. PubMed ID: 16087551 [TBL] [Abstract][Full Text] [Related]
44. Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study. Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Sleypen FA; Vles JS; Dev Med Child Neurol; 2007 Sep; 49(9):654-9. PubMed ID: 17718820 [TBL] [Abstract][Full Text] [Related]
46. [Intrathecal baclofen. Twenty years later]. Bussel B; Bensmail D Ann Readapt Med Phys; 2006 Jun; 49(5):252-3. PubMed ID: 16698110 [No Abstract] [Full Text] [Related]
47. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy. Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS; Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974 [TBL] [Abstract][Full Text] [Related]
48. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Woon K; Tsegaye M; Vloeberghs MH Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454 [TBL] [Abstract][Full Text] [Related]
49. Intrathecal Baclofen: a discussion on impact that medical advances can have on the individual and the implications this has for a society that is built on an ethic of social medicine. Baddeley AA Disabil Rehabil; 2008; 30(5):405-10. PubMed ID: 17852308 [TBL] [Abstract][Full Text] [Related]
50. In situ treatment of an infected intrathecal baclofen pump implant with gentamicin-impregnated collagen fleece. Peerdeman SM; de Groot V; Feller RE J Neurosurg; 2010 Jun; 112(6):1308-10. PubMed ID: 19731988 [TBL] [Abstract][Full Text] [Related]
51. Intrathecal baclofen for spasticity-related pain in amyotrophic lateral sclerosis: efficacy and factors associated with pain relief. McClelland S; Bethoux FA; Boulis NM; Sutliff MH; Stough DK; Schwetz KM; Gogol DM; Harrison M; Pioro EP Muscle Nerve; 2008 Mar; 37(3):396-8. PubMed ID: 17894358 [TBL] [Abstract][Full Text] [Related]
52. Identification and management of intrathecal baclofen pump complications: a comparison of pediatric and adult patients. Vender JR; Hester S; Waller JL; Rekito A; Lee MR J Neurosurg; 2006 Jan; 104(1 Suppl):9-15. PubMed ID: 16509474 [TBL] [Abstract][Full Text] [Related]
53. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity. Stokic DS; Yablon SA; Hayes A; Vesovic-Potic V; Olivier J Clin Neurophysiol; 2006 Jun; 117(6):1283-9. PubMed ID: 16621691 [TBL] [Abstract][Full Text] [Related]
54. [The need for psychological help for haemophilic children and their families]. Szaniawska-Thiel M; Laguna P Psychiatr Pol; 2007; 41(6):813-25. PubMed ID: 18540424 [TBL] [Abstract][Full Text] [Related]
55. Severe pain, spasticity, and heterotopic ossification in a patient with spinal cord injury: a vicious circle and management with baclofen pump. Yenigün D; Ekiz T; Yuzer GF; Tasoglu O; Aslan MD; Ozgirgin N Pain Physician; 2014; 17(6):E794-5. PubMed ID: 25415800 [No Abstract] [Full Text] [Related]
56. Intracranial hypotension from intrathecal baclofen pump insertion. A case report and review of the literature. Lad SP; Li G; Lin SC; Henderson JM Stereotact Funct Neurosurg; 2008; 86(2):75-9. PubMed ID: 18073519 [TBL] [Abstract][Full Text] [Related]
57. Managing spasticity with intrathecal drug delivery. Barker E RN; 2008 Apr; 71(4):24-9; quiz 30. PubMed ID: 18524352 [No Abstract] [Full Text] [Related]
58. [Physical and other methods therapy of the spasticity in children]. Swierczyńska A; Renata K; Jaworek M Przegl Lek; 2007; 64(11):974-7. PubMed ID: 18409416 [TBL] [Abstract][Full Text] [Related]
59. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. McCoy AA; Fox MA; Schaubel DE; Ayyangar RN Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127 [TBL] [Abstract][Full Text] [Related]
60. A review of the complications of intrathecal baclofen in patients with cerebral palsy. Kolaski K; Logan LR NeuroRehabilitation; 2007; 22(5):383-95. PubMed ID: 18162701 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]